GlassScriptPhysician profile
Steven Jay Fleischman
NPI 1265495790
$932.81
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $13.37 · 2021: $30.11 · 2022: $227 · 2023: $180 · 2024: $93.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $228.02 | 2019-2021 | |
| Astellas Pharma US INC | $206.60 | 2022-2024 | Veozah, Myrbetriq |
| Sanofi Pasteur INC. | $80.06 | 2023-2024 | |
| Exeltis, USA INC. | $58.61 | 2022-2023 | Tyblume, Slynd |
| Pfizer INC. | $46.46 | 2019 | |
| Therapeuticsmd, INC. | $43.49 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.77 | 2022 | |
| Myovant Sciences INC. | $40.21 | 2021-2022 | |
| Allergan, INC. | $39.00 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $37.51 | 2019 | |
| Becton, Dickinson and Company | $31.50 | 2022 | |
| Urovant Sciences INC | $18.91 | 2022 | |
| Mayne Pharma Commercial LLC | $18.25 | 2022 | |
| Avion Pharmaceuticals | $14.93 | 2019 | |
| Millicent US INC | $14.05 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Fleischman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.